Micro-RNA-130a-3p Regulates Gemcitabine&#160;Resistance via PPARG in Cholangiocarcinoma (Q36385805)

13 August 2017

title

Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma (English)

1 reference

13 August 2017

0 references

15

Masaki Mori

1 reference

13 August 2017

14

Yuichiro Doki

1 reference

13 August 2017

3

Hidetoshi Eguchi

1 reference

13 August 2017

16

Hideshi Ishii

1 reference

13 August 2017

9

Takehiro Noda

1 reference

13 August 2017

8

Tadafumi Asaoka

1 reference

13 August 2017

4

Masamitsu Konno

1 reference

13 August 2017

12

Naohiro Nishida

1 reference

13 August 2017

7

Daisaku Yamada

1 reference

13 August 2017

11

Kunihito Gotoh

1 reference

13 August 2017

1

Kei Asukai

1 reference

13 August 2017

5

Ayumu Asai

1 reference

13 August 2017

6

Yoshifumi Iwagami

1 reference

13 August 2017

13

Taroh Satoh

1 reference

13 August 2017

Koichi Kawamoto

2

1 reference

13 August 2017

Hiroshi Wada

series ordinal

10

1 reference

13 August 2017

publication date

30 May 2017

1 reference

Annals of Surgical Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

2344-2352

1 reference

Molecular pathogenesis of cholangiocarcinoma

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Pancreatic cancer: understanding and overcoming chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Dysregulation of miR-15a and miR-214 in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

PPARγ signaling and metabolism: the good, the bad and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

PPARγ is an E3 ligase that induces the degradation of NFκB/p65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Drug repositioning: identifying and developing new uses for existing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

Can you teach old drugs new tricks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-017-5871-X

10.1245/S10434-017-5871-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1085719543

0 references

1 reference